OSEL, INC.
- MOUNTAIN VIEW, CA 94043-4040
- oselinc.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 0
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
OSEL, INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About OSEL, INC.
- Headquarters
- MOUNTAIN VIEW, CA 94043-4040
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIR5DDHN86ANH9
- CAGE4KCX1
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
No federal prime awards on record
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 14 awards
- Total awarded
- $7,273,950
- By phase
- SBIR Phase I: 11
- SBIR Phase II: 3
- By agency
- Department of Health and Human Services: 14
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2025: 1
- 2020: 1
- 2016: 1
- 2014: 1
- 2012: 1
- 2010: 1
- 2005: 1
- 2003: 1
- 2002: 4
- 2001: 1
- 1999: 1
Awards (most recent first)
Novel Antimicrobial Approach to Treat Chemoradiation Resistant Cervical Cancer by Selectively Inhibiting Lactobacillus iners
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2025 · $295,881
May 20, 2025 – Apr 30, 2026
Solicitation PA23-230 (2023) · Topic 102
MucoCept-CVN, a genetically enhanced vaginal Lactobacillus strain for the prevention of HIV acquisition in women: Finalization of formulation for the first-in-human clinical trial
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2020 · $1,463,683
Aug 1, 2020 – Jul 31, 2022
- Direct to Phase II
Solicitation PA18-574 (2018) · Topic NIAID
Development of a rapid point of care diagnostic,to monitor MucoCept-CVN, an HIV-targeted biotherapy,
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $225,000
Apr 1, 2016 – Mar 31, 2018
Solicitation PA15-269 (2016) · Topic R
Delivery of passive immunity against HIV using commensal vaginal Lactobacillus bioengineered to secrete broadly neutralizing domain antibodies
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2014 · $2,724,048
Aug 7, 2014 – Jul 31, 2016
Solicitation PA13-088 (2014) · Topic NIAID
Delivery of passive immunity against HIV using commensal vaginal Lactobacillus bi
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $299,870
Solicitation PA11-096 (2012) · Topic NIAID
Development of Bacterial Therapeutics Targeting Bacterial Vaginosis-Associated Bi
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2010 · $198,503
Solicitation PHS2010-2 (2010)
Oral Immunotherapy for C. difficile Disease via Bacteria
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2005 · $121,667
Solicitation PHS2005-2 (2005)
Use of Modified Lactobacilli to Block HSV Transmission
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $145,089
USE OF MODIFIED LACTOBACILLI TO BLOCK HIV TRANSMISSION
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2002 · $100,000
DISPLAY OF HIV BINDING PROTEINS ON BACTERIAL S-LAYERS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2002 · $135,156
NEUTRALIZATION OF HIV BY MODIFIED LACTOBACILLI
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2002 · $1,296,572
NEUTRALIZATION OF HIV BY MODIFIED LACTOBACILLI
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2002 · $0
Neutralization of HIV by bifunctional proteins
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2001 · $139,650
NEUTRALIZATION OF HIV BY GENETICALLY-MODIFIED LACTOBACIL
SBIR Phase I · Department of Health and Human Services · 1999 · $128,831
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325412Pharmaceutical Preparation ManufacturingPrimarySmall business under this code’s size standard
SAM.gov reports this entity as small under 1 of 1 NAICS code. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with OSEL, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
